Skip to main navigation Skip to search Skip to main content

Nivolumab after sorafenib failure in liver recipients with hepatocellcular carcinoma recurrence

  • Sungkyunkwan University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nivolumab after sorafenib failure in liver recipients with hepatocellcular carcinoma recurrence'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry